Article Information
History
- April 26, 2016.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- T. Simakova1,
- A. Bragin1,
- M. Zaytseva1,
- C. Clemente2,
- M. Lewicka2,
- J.C. Machado3,4,
- J.L. Costa3,4,
- M. Hughes5,
- C. Hertz-Fowler5,
- N. Petrova6,
- A. Polyakov6,
- R. Zinchenko6,7,
- E. Kondratyeva6 and
- A. Pavlov1,*
- 1Parseq Lab Company, Saint Petersburg, Russia
- 2Stab Vida Company, Caparica, Portugal
- 3Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Portugal
- 4Institute of Molecular Pathology and Immunology (Ipatimup), University of Porto, Porto, Portugal
- 5Centre for Genomic Research University of Liverpool, Liverpool, United Kingdom
- 6Federal State Budgetary Institution “Research Centre for Medical Genetics”, Moscow, Russia
- 7Pirogov Russian National Research Medical University, Moscow, Russia
- ↵*Corresponding author: apavlov{at}parseq.pro